Thyrocare Technologies Limited (NSE:THYROCARE)

Market Cap	74.23B +53.5%
Revenue (ttm)	8.29B +20.6%
Net Income	1.63B +78.2%
EPS	10.24 +78.3%
Shares Out	n/a
PE Ratio	45.52
Forward PE	40.87
Dividend	9.33 (1.98%)
Ex-Dividend Date	Oct 24, 2025

Volume	122,081
Average Volume	903,443
Open	469.95
Previous Close	469.05
Day's Range	460.10 - 469.95
52-Week Range	291.37 - 536.67
Beta	0.35
RSI	61.28
Earnings Date	May 7, 2026

About Thyrocare Technologies

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the bran...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1996
• Employees: 1,822
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: THYROCARE

Financial Performance

In fiscal year 2026, Thyrocare Technologies's revenue was 8.29 billion, an increase of 20.61% compared to the previous year's 6.87 billion. Earnings were 1.63 billion, an increase of 78.18%.